HKSE:02630 (China)
Â
Class H
HK$
90.7
-1.2 (-1.31%)
Aug 16
Business Description
Vigonvita Life Sciences Co Ltd
ISIN : CNE1000076N3
Share Class Description:
HKSE:02630: Class HTotal Employee Number:
315Compare
Compare
Traded in other countries / regions
02630.Hong Kong IPO Date
2025-11-06Description
Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.8 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.45 | |||||
Debt-to-EBITDA | -2.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.42 | |||||
Beneish M-Score | 2.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.91 | |||||
9-Day RSI | 46.12 | |||||
14-Day RSI | 51.12 | |||||
3-1 Month Momentum % | -33.89 | |||||
6-1 Month Momentum % | -51.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.99 | |||||
Days Inventory | 80.74 | |||||
Days Sales Outstanding | 27.04 | |||||
Days Payable | 78.87 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.02 | |||||
Operating Margin % | -308.72 | |||||
Net Margin % | -348.42 | |||||
EBITDA Margin % | -298.26 | |||||
FCF Margin % | -255.13 | |||||
OCF Margin % | -94.69 | |||||
ROE % | -120.44 | |||||
ROA % | -35.73 | |||||
ROIC % | -33.3 | |||||
ROC (Joel Greenblatt) % | -72.95 | |||||
ROCE % | -59.47 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 122.74 | |||||
PB Ratio | 30.85 | |||||
Price-to-Tangible-Book | 50.39 | |||||
EV-to-EBIT | -40.42 | |||||
EV-to-EBITDA | -45.6 | |||||
EV-to-Revenue | 136.01 | |||||
EV-to-FCF | -53.31 | |||||
Earnings Yield (Greenblatt) % | -2.47 | |||||
FCF Yield % | -1.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vigonvita Life Sciences Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 112.788 | ||
| EPS (TTM) (HK$) | -2.574 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 51.12 | ||
| 14-Day ATR (HK$) | 10.7885 | ||
| 20-Day SMA (HK$) | 93.245 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 51 - 134.9 | ||
| Shares Outstanding (Mil) | 167.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vigonvita Life Sciences Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vigonvita Life Sciences Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vigonvita Life Sciences Co Ltd Frequently Asked Questions
What is Vigonvita Life Sciences Co Ltd(HKSE:02630)'s stock price today?
The current price of HKSE:02630 is HK$90.70. The 52 week high of HKSE:02630 is HK$134.90 and 52 week low is HK$51.00.
When is next earnings date of Vigonvita Life Sciences Co Ltd(HKSE:02630)?
The next earnings date of Vigonvita Life Sciences Co Ltd(HKSE:02630) is .
Does Vigonvita Life Sciences Co Ltd(HKSE:02630) pay dividends? If so, how much?
Vigonvita Life Sciences Co Ltd(HKSE:02630) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vigonvita Life Sciences Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers